Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics | Apply Online

FAQs: Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics (CDC/HHS)

What is the title of this funding opportunity?

The funding opportunity is titled "Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics."

Which federal agency is offering this opportunity?

This opportunity is offered by the U.S. Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC).

What type of funding mechanism is being used?

The mechanism is a cooperative agreement.

What does it mean that this is a cooperative agreement?

Based on the description provided, a cooperative agreement generally indicates substantial CDC involvement during the project period. This can include collaboration on work plans, alignment on methods, shared decision-making around deliverables, and iterative review of products.

What is the opportunity category?

The opportunity category is listed as "Continuation."

What does "Continuation" imply for this opportunity?

This is presented as a continuation action connected to an existing funded effort, rather than a broad, new open solicitation. Continuation opportunities typically support ongoing work under an existing project or award, with funding extended or renewed based on progress and continued programmatic need.

Is this a new competitive grant open to a wide field of applicants?

The information provided suggests it is not positioned as a broad new competition. Because it is explicitly labeled as a continuation cooperative agreement, it may be intended to support ongoing work and may be limited to current recipient(s) or a specific set of eligible organizations.

What is the main purpose or focus of the funding opportunity?

The central focus is to strengthen how laboratory practice guidelines are evaluated by developing or applying a newer, more effective approach to metrics. The opportunity is oriented toward improving how the impact of laboratory guidelines is measured, tracked, and demonstrated.

What does the phrase "a new paradigm for metrics" suggest in practical terms?

It suggests an emphasis on improving the measurement framework used to evaluate laboratory practice guidelines, potentially through better performance indicators, clearer outcome measurement, and more actionable evaluation approaches that demonstrate whether guidelines are adopted and whether they improve laboratory quality and public health practice.

Is the opportunity about creating new laboratory practice guidelines?

Based on the provided description, the emphasis is not simply on producing guidelines. Instead, the emphasis is on measuring and demonstrating whether guidelines change practice or improve outcomes.

What activity category is associated with this opportunity?

It falls under the health activity category.

What is the CFDA number for this opportunity?

The opportunity is associated with CFDA number 93.064.

Who is eligible to apply?

Eligibility is listed as "Others," with a note indicating that additional eligibility details would be found in an additional eligibility text field. That detailed eligibility language is not included in the information provided here. The "Others" category commonly indicates eligibility may be limited to a specific set of organizations or possibly the current recipient(s) of the underlying cooperative agreement.

Does the provided information confirm whether new applicants can apply?

No. The provided information does not include the detailed eligibility language, and the continuation category suggests it may not be open to first-time applicants. Confirmation would normally require reviewing the full announcement.

Is there an award ceiling listed?

No award ceiling is specified in the information provided.

Is there an expected number of awards listed?

No expected number of awards is provided in the information available.

What might it mean that the award ceiling and number of awards are not specified?

As described in the provided information, this often suggests an administrative continuation action where the amount and recipient(s) may already be established under prior cycles.

What are the key dates for this opportunity?

The opportunity was created and posted on March 1, 2016. The original closing date and the current closing date are both April 15, 2016.

Has the closing date changed?

Based on the information provided, no. Both the original closing date and the current closing date are listed as April 15, 2016.

What kinds of outcomes is this effort trying to better demonstrate?

The description emphasizes demonstrating whether laboratory practice guidelines are being adopted and whether they are improving laboratory quality and public health practice, using improved metrics and evaluation approaches.

What level of CDC involvement should an awardee expect?

The provided information indicates substantial involvement typical of cooperative agreements, such as collaboration on work plans, alignment on methods, shared decision-making on deliverables, and iterative review of products.

What is the best summary of this opportunity based on the provided text?

It is CDC support for continuing work focused on improving how the real-world impact of laboratory practice guidelines is measured, with an emphasis on a "new paradigm" for metrics that can better track, quantify, and demonstrate adoption and outcomes.